Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
International Journal of Molecular Sciences(1)
Journal of Neurochemistry(1)
Pharmaceuticals(1)
Pharmacological Research(1)
Origen
scopus(4)
A metabolic perspective of late onset Alzheimer's disease
ReviewAbstract: After decades of research, the molecular neuropathology of Alzheimer's disease (AD)is still one of tPalabras claves:Alzheimer's disease, c-Jun N-terminal kinase inhibitors, Insulin, Licochalcone A, neuroinflammation, Reticulum stress, Type 2 Diabetes mellitusAutores:Antoni Camins, Auladell C., Busquets O., Cano A., Castro-Torres R.D., Ettcheto M., Folch J., García M.L., Manzine P.R., Olloquequi J., Sanchez-Lopez E., Verdaguer E., Zárate C.B.Fuentes:scopusRole of brain c-Jun N-terminal kinase 2 in the control of the insulin receptor and its relationship with cognitive performance in a high-fat diet pre-clinical model
ArticleAbstract: Insulin resistance has negative consequences on the physiological functioning of the nervous system.Palabras claves:ER stress, high-fat diet, JNK, metabolism, neuroinflammation, PTP1BAutores:Antoni Camins, Auladell C., Busquets O., Castro-Torres R.D., Eritja À., Ettcheto M., Folch J., López B.M., Manzine P.R., Olloquequi J., Vázquez-Carrera M., Verdaguer E.Fuentes:scopusRole of c-jun N-terminal kinases (JNKs) in epilepsy and metabolic cognitive impairment
ReviewAbstract: Previous studies have reported that the regulatory function of the different c-Jun N-terminal kinasePalabras claves:BRAIN, C-Jun-N-terminal kinase, cognitive impairment, Epilepsy, JNK inhibitor, metabolism, Type 2 DiabetesAutores:Antoni Camins, Auladell C., Busquets O., Cano A., Castro-Torres R.D., Espinosa-Jimenez T., Ettcheto M., Folch J., Manzine P.R., Olloquequi J., Sanchez-Lopez E., Sureda F.X., Verdaguer E., Zárate C.B.Fuentes:scopusThe implication of the brain insulin receptor in late onset Alzheimer’s disease dementia
ArticleAbstract: Alzheimer’s disease (AD) is progressive neurodegenerative disorder characterized by brain accumulatiPalabras claves:Alzheimer’s, amyloid, COGNITION, insulin receptor, Insulin Resistance, Tau, Type 2 DiabetesAutores:Antoni Camins, Auladell C., Busquets O., Castro-Torres R.D., Ettcheto M., Folch J., García M.L., Manzine P.R., Olloquequi J., Poor S.R., Sanchez-Lopez E., Verdaguer E., Zárate C.B.Fuentes:scopus